PIJIP Projects: Access to Medicines, Competition Policy Project

PIJIP is building a competition law and intellectual property backup project to provide economic and legal research and analysis to support access to medicines activists around the world. This project will (1) commission expert economic and legal research into competition law theories that support access to needed medicines in developing countries, (2) sponsor international conferences and meetings to test and share ideas at the intersection of intellectual property, competition law and access to medicines, and (3) disseminate the knowledge created through these activities through publications, a dedicated website, webcasts and podcasts of meetings and through other means.

Recent PIJIP Scholarship

South African Activists File Competition Complaint Against Merck for Refusal to License Efavirenz Patents

Abbott's Refusal to Register New Products in Thailand (2007)

KEI Complaint against Gilead (2007)

Documents from Hazel Tau v. GSK, et. al. (2003)

Announcements of Compulsory Licenses Issued by the Italian Antitrust Authority

Selected Competition Legislation


Working group on Competition & Access to Medicines

On February 15, 2007, PIJIP organized the first meeting of the Working Group on Competition and Access to Medicines. The meeting was attended by PIJIP, Knowledge Ecology International (Formerly Consumer Project on Technology), Essential Action, Oxfam America, Health GAP and the AIDS Law Project South Africa. The meeting discussed KEI's recent complaint to the FTC against Gilead and reviewed other documents and research on using competition law to promote access to medicines. The group resolved to convene future meetings on competition law and voluntary license terms for AIDS drug patents.